Announcements Trials
Browse Landscape

Phase

Phase 3 11Phase 2 6Phase NA 2Phase 1 2Phase 2/3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Glioblastoma 2Central Nervous System Neoplasms 2Medulloblastoma 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma 1Glioma 1

Interventions

Magnetic Resonance Spectroscopy 8Radiotherapy 7Temozolomide 5Carboplatin 5Vincristine 4etoposide phosphate 3Methotrexate 3Etoposide 3Busulfan 3Biopsy 3Thiotepa 2Surveys and Questionnaires 2Melphalan 2Magnetic Resonance Imaging 2Lomustine 2Cisplatin 2Chemotherapy, Adjuvant 2alovudine 1Yoga 1Ursodeoxycholic Acid 1Topotecan 1Stem Cell Transplantation 1Rituximab 1Remote Consultation 1Radiation 1Psychiatric Rehabilitation 1Peripheral Blood Stem Cell Transplantation 1Paclitaxel 1Oxycodone 1Ocoxin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Central Nervous System Neoplasms × Lomustine × Clear all
NCT00058370 2020-05-11

Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma

Memorial Sloan Kettering Cancer Center

Phase NA Completed
6 enrolled 8 charts
CNS

Medulloblastoma, Central Nervous System Neoplasms

NCT00303810 2014-01-28

Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma

Universitätsklinikum Hamburg-Eppendorf

Phase NA Completed
567 enrolled
CNS

Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡